Mark Lotter


Mr. Lotter has significant experience working in one of the leading global Big Pharma companies, including in China, and since has been a successful entrepreneur. He was the Chief Executive Officer of China Operations at SciClone Pharmaceuticals, Inc and before that he founded and served as the Chief Executive Officer and President of NovaMed Pharmaceuticals Inc. Prior to that he served as Vice President, Commercial Operations of AstraZeneca China.